ClearSky Medical Diagnostics has been selected as a UK Life Sciences Innovator 2023 by the UK’s Department for International Trade (DIT).
After a rigorous selection process, we are one of 57 companies chosen to showcase the best of UK innovation at global life sciences events across 2023.
The DIT officially launched the UK Life Sciences Innovators Showcase in January at Arab Health, the largest healthcare event of its kind in the Middle East.
ClearSky MD features in the Digital Solutions category of the UK Life Sciences Innovators 2023 directory of innovators at the forefront of life sciences innovation looking to deliver solutions globally.
Professor Stephen L. Smith, co-founder and director of ClearSky Medical Diagnostics, said: “We are very excited and proud to be selected as a UK Life Sciences Innovator 2023.
“It is fantastic recognition for our work in developing intelligent medical devices which utilise patented White/Open Box machine learning algorithms for the diagnosis and monitoring of Parkinson’s, Alzheimer’s and related conditions.”
“The core technology behind ClearSky’s devices is based on unique biologically-inspired computer algorithms developed at the University of York in close collaboration with leading medical centres worldwide.”
Comentários